HSA — authorised 29 July 1999
- Marketing authorisation holder: ORGANON USA INC
- Status: likely_approved
HSA authorised Ganirelix Acetate on 29 July 1999
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 29 July 1999.
ORGANON USA INC holds the Singaporean marketing authorisation.